SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-035295
Filing Date
2022-10-26
Accepted
2022-10-26 17:11:09
Documents
57
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vktx-10q_20220930.htm   iXBRL 10-Q 2659685
2 EX-31.1 vktx-ex311_7.htm EX-31.1 20484
3 EX-31.2 vktx-ex312_6.htm EX-31.2 20462
4 EX-32.1 vktx-ex321_8.htm EX-32.1 12589
  Complete submission text file 0001564590-22-035295.txt   9080900

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vktx-20220930.xsd EX-101.SCH 54229
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20220930_cal.xml EX-101.CAL 44477
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20220930_def.xml EX-101.DEF 178816
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20220930_lab.xml EX-101.LAB 419951
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20220930_pre.xml EX-101.PRE 326568
51 EXTRACTED XBRL INSTANCE DOCUMENT vktx-10q_20220930_htm.xml XML 1751152
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 221334057
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences